Abstract
Diabetes Mellitus is a disease which is defined as increased blood glucose (sugar) levels than normal. This is additionally called hyperglycemia. A large pharmacological treatment is available for diabetes but have some limitations, like different drug responses among individuals, failure to achieve glycemic control, and adverse effects. Pharmacogenomics is an emerging new branch of science which deals with the relationship between genomic variations for development of effective doses and safe medications according to an individual patient genetic makeup. Two important roles of Pharmacogenomics in precision medicine; one is drug discovery and development and other in selecting the correct drug for patients based on their genetic make-up by avoiding Adverse Drug Reactions, and in maximizing drug efficacy. This review article summarizes the type of diabetes, pharmacogenomics, personalized medicine and role of pharmacogenomics in drug development.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
